RUBICON RESEARCH LIMITED Share Price

₹ 1,659.30

-₹81.30 (-4.67%)
1D
Last updated 06 Nov, 2026, 15:59 IST
NSE: RUBICON
|
Pharmaceuticals

RUBICON RESEARCH LIMITED Share Price Today

As of 7 Nov 2026, RUBICON RESEARCH LIMITED share price is ₹1,659.30. The stock opened at ₹1,769.00, compared to its previous close of ₹1,740.60. During today's trading session, RUBICON RESEARCH LIMITED share price moved in the range of ₹1,606.00 to ₹1,769.00, with an average price of ₹1,687.50 for the day. Looking at its last 52-week, the stock has touched a low of ₹609.25 and a high of ₹1,899.00. On the performance front, RUBICON RESEARCH LIMITED share price has increased by 65.62% over the last six months and is up 159.87% on a year-on-year basis.

Share price over the last 1 day fell from 1688.00 to 1650.10, ranging between 1608.40 and 1703.00.
₹1,606.00
4.67% down today
₹1,769.00
1D LOW
1D HIGH

RUBICON RESEARCH LIMITED Stock Insights

Latest Earning
Op Profit TrendUp by 11.84% QoQ
Latest Earning
Net Profit TrendUp by 10.41% QoQ
Latest Earning
Revenue TrendUp by 4.55% QoQ
Stock Performance
OutperformingBeat Nifty by 1.28 % in last 1 month
Shareholding Pattern
PromoterPromoter decreased stake by 14.24%
Shareholding Pattern
DIIDII decreased stake by 92.90%
Shareholding Pattern
FIIFII increased stake by 19.81%
RUBICON RESEARCH LIMITED stock performance
Open₹1,769.00
High₹1,769.00
Low₹1,606.00
Prev. close₹1,740.60
RUBICON RESEARCH LIMITED trading activity
Volume6,88,952
Average traded price₹1,652.35
Last traded time03:59:01 06 Nov
Last traded quantity63
Circuit
L
H
₹1,327.50
₹1,991.10
52-week
L
H
₹609.25
₹1,899.00
Mkt Cap Cr
28,415.62
P/E
99.96
P/B
22.35
ROA
10.44%
ROE
19.14%
ROCE
22.56%
Quick Ratio
1.14
EV/EBITDA
61.3

Based on fundamentals, this stock's

Performance: 5 out of 5, Excellent
Performance
Excellent
Rubicon Research outperforming all market indices
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Rubicon Research appears overvalued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Rubicon Research revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,121.8939.864.919.61%13.79%18.65%2.3122.22
Divis Laboratories2,69,450.6192.1216.0814.6%15.32%19.56%3.560.54
Torrent Pharmaceuticals1,79,455.6585.929.814.7%11.42%11.37%0.7534.26
Laurus Labs1,26,703.2294.6920.8211.58%22.11%20.91%0.6853.44
Zydus Lifesciences1,19,341.3627.744.297.63%15.1%14.86%0.9115.88
Dr. Reddy's Laboratories1,14,532.4441.192.934.79%7.21%8.58%1.3519.35
Cipla1,13,243.2639.683.26.6%8.18%10.8%2.521.38
Mankind Pharma1,04,913.4545.895.917.82%12.76%14.68%0.7425.45
Aurobindo Pharma1,03,395.4125.812.616.46%10.13%12.76%1.1511.76
Lupin90,886.9817.433.7813.08%21.65%24.54%1.4210.19

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

RUBICON RESEARCH LIMITED Company Background

ISIN
INE506V01022
Sector Market Cap
₹ 28,415.62 Cr

Rubicon Research Ltd is an India-based pharmaceutical formulations company, which is focused on research and development, with a portfolio of specialty products and drug-device combination products targeting regulated markets, and particularly the United States. Its portfolio spans multiple dosage forms, including oral solids, oral liquids, nasal, and topical. Its technologies include RubiReten and RubiSRL. Its services include intellectual property evaluation and product design, formulation research development, analytical research development, technology transfer, dossier compilation and regulatory support, and clinical trials supplies. Its products are spread across many therapeutic areas, such as Analgesics/Pain Management, CVS, CNS, Hypokalemia, Skeletal Muscle Relaxants, NRT, Gastrointestinal, Metabolic, Immunosuppressant, and others. Others include Antipyretic, Hormonal Products, Diuretic, Antimuscarinics, Oral Rehydration Therapy, Over the Counter products, and Respiratory.

RUBICON RESEARCH LIMITED Financial Highlights

  • Revenue: RUBICON RESEARCH LIMITED reported revenue of ₹1,761.69 crore in FY26 vs ₹1,287.90 crore in FY25. It showed an increase of 36.79% on a yearly basis.
  • Operating Profit: RUBICON RESEARCH LIMITED reported an operating profit of ₹320.53 crore in FY26 vs ₹194.52 crore in FY25. It showed an increase of 64.78% on a year-on-year basis.
  • Net Profit: RUBICON RESEARCH LIMITED reported a net profit of ₹246.74 crore in FY26 vs ₹134.36 crore in FY25. It showed an increase of 83.64% on a yearly basis.

RUBICON RESEARCH LIMITED Quarterly Result Highlights

  • RUBICON RESEARCH LIMITED reported revenue of ₹540.02 crore in Jun 2026, compared with ₹516.53 crore in Mar 2026, representing an increase of 4.55% on a quarter-on-quarter (QoQ) basis.
  • RUBICON RESEARCH LIMITED reported an operating profit of ₹110.37 crore in Jun 2026, compared with ₹98.69 crore in Mar 2026, representing an increase of 11.84% on a quarter-on-quarter (QoQ) basis.
  • RUBICON RESEARCH LIMITED reported a profit of ₹84.78 crore in Jun 2026, compared with ₹76.79 crore in Mar 2026, reflecting an increase of 10.41% on a QoQ basis.
  • The earnings per share (EPS) of RUBICON RESEARCH LIMITED stood at ₹15.52 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
51.25%
FII
9.01%
Other DII
0.16%
Retail and other
25.81%
Mutual funds
13.78%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20258.00%
Mar 20267.54%
Jun 20267.52%
Sep 20269.01%

RUBICON RESEARCH LIMITED Investment Returns

1 day
-4.67%
1 week
+3.03%
1 month
+3.91%
1 year
+159.87%
3 years
+164.14%
5 years
+164.14%

RUBICON RESEARCH LIMITED Share Price History

RUBICON RESEARCH LIMITED share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
06 Nov 26
₹1,769.00 / ₹1,659.30
-4.67%
05 Nov 26
₹1,721.50 / ₹1,740.60
+1.39%
04 Nov 26
₹1,718.00 / ₹1,716.80
-0.07%
03 Nov 26
₹1,694.90 / ₹1,718.00
+3.03%
Show more

RUBICON RESEARCH LIMITED Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,753.96₹1,284.27₹853.89₹393.52
Other Income₹7.73₹3.63₹18.50₹25.48
Total Revenue₹1,761.68₹1,287.91₹872.39₹419.00
Total Expenses₹1,441.15₹1,093.38₹769.53₹430.05
Profit Before Tax₹320.53₹194.52₹102.86-₹11.05
Tax₹73.80₹60.16₹11.85₹5.84
Profit After Tax₹246.74₹134.36₹91.01-₹16.89
EPS - Basic₹15.52₹8.82₹5.98-₹1.11
EPS - Diluted₹15.31₹8.68₹5.91-₹1.11

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹320.53₹194.52₹102.86-₹11.05
Income before WC changes₹428.15₹287.93₹174.17₹35.18
Change in Assets-₹381.28-₹244.21-₹241.49-₹162.98
Change in Liabilities₹266.68₹154.21₹106.40₹54.87
Change in WC-₹114.60-₹90.00-₹135.08-₹108.11
Cash flow from Operations₹205.05₹159.18₹21.01-₹74.75
Cash flow from Investing-₹409.72-₹64.81-₹68.51-₹33.82
Cash flow from Financing₹283.07-₹39.81₹43.55₹122.81
Total Cash Flow₹78.39₹54.56-₹3.95₹14.24
Cash (Start of the year)₹104.98₹50.60₹54.43₹38.67
Cash (End of the year)₹185.65₹104.98₹50.61₹54.43

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹644.91₹388.07₹346.32₹248.12
Current Assets₹1,681.81₹1,063.37₹763.17₹501.59
Total Assets₹2,326.71₹1,451.43₹1,109.49₹749.70
Current Liabilities₹835.87₹786.03₹572.50₹361.32
Net Current Asset₹845.94₹277.34₹190.67₹140.27
Non-Current Liabilities₹202.03₹124.42₹151.99₹102.01
Equity Capital₹1,288.82₹540.99₹385.00₹286.38
Total Equity & Liabilities₹2,326.71₹1,451.43₹1,109.49₹749.70

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,306.08₹1,073.84₹630.51₹393.52
Other Income₹10.83₹19.68₹26.43₹25.48
Total Revenue₹1,316.91₹1,093.52₹656.94₹419.00
Total Expenses₹1,064.14₹870.24₹622.87₹430.05
Profit Before Tax₹252.78₹223.28₹34.07-₹11.05
Tax₹64.61₹55.74₹9.73₹5.84
Profit After Tax₹188.17₹167.54₹24.35-₹16.89
EPS - Basic₹11.83₹11.00₹1.60-₹1.11
EPS - Diluted₹11.67₹10.82₹1.58-₹1.11

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹252.78₹223.28₹34.07-₹11.05
Income before WC changes₹328.41₹291.63₹85.60₹35.18
Change in Assets-₹292.10-₹331.90-₹15.99-₹162.98
Change in Liabilities₹96.60₹96.78₹29.47₹54.87
Change in WC-₹195.49-₹235.12₹13.49-₹108.11
Cash flow from Operations₹38.71₹29.65₹83.20-₹74.75
Cash flow from Investing-₹271.79-₹10.03-₹130.49-₹33.82
Cash flow from Financing₹296.72-₹34.05₹45.86₹122.81
Total Cash Flow₹63.64-₹14.43-₹1.42₹14.24
Cash (Start of the year)₹25.85₹40.47₹41.76₹38.67
Cash (End of the year)₹91.78₹25.85₹40.47₹54.43

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹561.00₹390.61₹446.09₹248.12
Current Assets₹1,414.50₹950.32₹570.51₹501.59
Total Assets₹1,975.50₹1,340.94₹1,016.60₹749.70
Current Liabilities₹456.82₹588.54₹431.25₹361.32
Net Current Asset₹957.69₹361.78₹139.26₹140.27
Non-Current Liabilities₹165.42₹84.61₹109.48₹102.01
Equity Capital₹1,353.27₹667.79₹475.87₹286.38
Total Equity & Liabilities₹1,975.50₹1,340.94₹1,016.60₹749.70
* All values are in INR Crore
RUBICON RESEARCH LIMITED market depth
Bid quantityBid priceAsk priceAsk quantity
001659.388
0000
0000
0000
0000
Total bid quantity0
Total ask quantity88
RUBICON RESEARCH LIMITED technical summary
Bearish indicators1
Neutral indicators6
Bullish indicators1
OverallNeutral
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
56.1
Neutral
ATR (14)
70.69
Neutral
STOCH(9,6)
61.39
Neutral
STOCH RSI (14)
71.16
Neutral
ADX(9)
37.66
Bearish
UO(9)
56.08
Neutral
ROC(12)
14.55
Bullish
WillR(14)
-28.98
Neutral
Period
Simple value
Exponential vaue
5D
1690.66
1687.85
10D
1600.09
1633.9
20D
1551.53
1602.58
50D
1660.78
1601.18
100D
1580.61
1518.18
Volume trend — traded volume by day
6 Nov6L
5 Nov2L
4 Nov0L
3 Nov1L
2 Nov3L
Average3L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

RUBICON RESEARCH LIMITED
Pharmaceuticals
Add Stock
Add Another

Mutual Funds Invested in RUBICON RESEARCH LIMITED

Fund name
AUM
PGIM India Healthcare Fund
5.29%
Bajaj Finserv Healthcare Fund
3.70%
Bajaj Finserv Small Cap Fund
3.05%

RUBICON RESEARCH LIMITED Returns Calculator

Ex-date: 07 Aug 2026

RUBICON RESEARCH LIMITED Latest News

2 months ago
NIFTY50, SENSEX today: Wall Street cues, FII activity, key things to know before markets open on August 27
2 months ago
Block deals, August 26: Welspun Corp tumbles 6% after ₹1,433 crore trade; PhysicsWallah, 2 others see big deals
3 months ago
Against the tide: Bajaj Auto, Lenskart, TVS Motor among 10 stocks that hit 52-week high on July 23
4 months ago
Sterlite Tech, Aditya Infotech, Park Medi World, HFCL among top 10 stocks with 100%+ returns in 2026
Showing news item 1 of 4

Top Gainers

TTML Share Price
₹39.77
+4.44 (+12.57%)
LINDEINDIA Share Price
₹6859.00
+551 (+8.73%)
APLLTD Share Price
₹965.15
+71.65 (+8.02%)
YESBANK Share Price
₹17.20
+0.96 (+5.91%)
HAVELLS Share Price
₹1128.00
+59.9 (+5.61%)
See more

Top Losers

THERMAX Share Price
₹2746.30
-573.4 (-17.27%)
HAPPYFORGE Share Price
₹1694.50
-188.2 (-10%)
ASTRAL Share Price
₹1253.60
-134.4 (-9.68%)
APARINDS Share Price
₹14106.00
-1507 (-9.65%)
REDINGTON Share Price
₹327.50
-28.9 (-8.11%)
See more

RUBICON RESEARCH LIMITED Share Price FAQs

Please be aware that RUBICON RESEARCH LIMITED stock prices are subject to continuous fluctuations due to various factors.